Status: Approved
Entry Type: Oligosaccharide
Molecule Category: Parent
ATC: B01AB10

Pharmacology

Primary Target
serpin family C member 1

Indications

Mesh Heading Maximum Phase Reference
Embolism; Pulmonary Embolism; Thromboembolism; Thrombosis; Venous Thromboembolism; Venous Thrombosis Phase 3 ClinicalTrials
Embolism; Pulmonary Embolism Phase 4 ClinicalTrials
Adenocarcinoma; Colorectal Neoplasms Phase 3 ClinicalTrials
Lymphoma; Multiple Myeloma; Neoplasms, Plasma Cell Phase 2 ClinicalTrials
Thromboembolism; Thrombosis; Venous Thromboembolism; Venous Thrombosis Phase 4 ClinicalTrials
Thromboembolism; Venous Thromboembolism Phase 4 ClinicalTrials
Thrombosis; Venous Thrombosis Phase 2/Phase 3 ClinicalTrials
Birth Weight; Fetal Growth Retardation Phase 4 ClinicalTrials
Kidney Failure, Chronic; Renal Insufficiency Phase 4 ClinicalTrials

Related Entries

UNKNOWN